Medical News

RSS

FDA approves Taro Pharmaceutical Industries' Fluorouracil Topical Cream ANDA

Taro Pharmaceutical Industries Ltd. today reported that it received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Fluorouracil Topical Cream USP, 5%.

8 Mar 2010

BioSpecifics Technologies' XIAFLEX now available to Dupuytren's contracture patients in the U.S.

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.

8 Mar 2010

How health reform could affect 'young invincibles'

In this Kaiser Health News story, produced in collaboration with USA Today, KHN staff writer Phil Galewitz writes about how the so-called young invincibles would be impacted by pending health reform proposals.

8 Mar 2010

FDA grants Axis Surgical Technologies marketing clearance for C-MOR Visualization Device

Axis Surgical Technologies, Inc., announced today that it has received 510(k) clearance from the Food and Drug Administration to market their C-MOR™ Visualization Device for use in diagnostic and operative arthroscopic and endoscopic procedures. The self-contained portable direct-imaging tool provides illumination and visualization of an interior cavity through either a natural or surgical opening.

8 Mar 2010

Fact check: Do 15,000 people lose insurance every day?

CNN's Political Ticker blog fact checks a statement made by Health and Human Services Secretary Kathleen Sebelius on NBC's "Meet the Press" Sunday. Sebelius said that "15,000 people a day lose their insurance."

8 Mar 2010

State of Pennsylvania awards Medicaid managed care contract to Aetna Better Health

The State of Pennsylvania notified Aetna that it has awarded a Medicaid managed care contract to Aetna Better Health,SM Aetna’s Medicaid business.

8 Mar 2010

White House emphasizes rising health insurance costs as reason for reform

The Los Angeles Times analyzes how insurance costs became a focal point: "The Democrats' bill was in serious trouble when news broke of planned rate hikes by the California insurer. ... Anthem Blue Cross was seeking double-digit rate increases for many of its 800,000 individual policyholders. Company executives had little reason to worry. Insurers can raise premiums in the individual market as often -- and as much -- as they like, within certain guidelines. For years, such requests were routinely approved."

8 Mar 2010

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Rcadia Medical Imaging today announced that it has received a CE Mark for the COR Analyzer® System, its proprietary software that helps identify patients with significant CAD (Coronary Artery Disease) by a fully automatic analysis of coronary CT angiography (cCTA) studies. The CE Mark allows the company to market the system in the European Union and other countries that accept the CE Mark registration. The COR Analyzer is marketed in the U.S. under 510(k) clearance and Rcadia was named 2009 Best New Radiology Vendor by AuntMinnie.com.

8 Mar 2010

Reconciliation update: Some Dems, GOP and industry groups wary health bill strategy

The Los Angeles Times: "Obama's signature ability to inspire fellow Democrats and Pelosi's well-honed ability to read their parochial needs will be tested as they tackle the job of finding the last stubborn votes for the healthcare bill. ... "Under the Democrats' strategy, the House would pass the Senate's version of the bill. Then both chambers would approve changes under the budget reconciliation process, which could pass the Senate with a simple 51-vote majority. Democrats hope to finish by the end of the month" (Hook and Levey, 3/8).

8 Mar 2010

Response Genetics to raise $4M from private placement of over 3M newly issued shares

Response Genetics, Inc. announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.

8 Mar 2010

invendo medical seeks premarket clearance for new C20 colonoscopy system

invendo medical announced today that the company has filed its 510(k) notice submission with the Food and Drug Administration for premarket clearance of the company's new C20™ colonoscopy system including the SC20™ single-use colonoscope. This is the first FDA submission for invendo medical in the United States.

8 Mar 2010

Repeated anaesthesia in children linked to memory impairment

There is a link between repeated anaesthesia in children and memory impairment, though physical activity can help to form new cells that improve memory, reveals new research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

8 Mar 2010

Prism Medical announces revenues of $65.7M for fiscal 2009

Prism Medical Ltd. today announced its results for the fiscal year ended November 30, 2009.

8 Mar 2010

Positive interim results from NxStage Medical's FREEDOM study in RLS

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy with the NxStage System One™.

8 Mar 2010

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the fourth quarter and year ended December 31, 2009.

8 Mar 2010

Rexahn Pharmaceuticals granted Japanese patent for Archexin

Rexahn Pharmaceuticals, Inc, a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin®.

8 Mar 2010

Gentiva Health Services acquires Heart to Heart Hospice

Gentiva Health Services, Inc., a leading provider of home health and hospice services, announced today that it has acquired Mississippi-based Heart to Heart Hospice.

8 Mar 2010

Replication Medical receives CE mark for GelFix Posterior Spinal Distraction implant

Replication Medical, Inc., a developer of proprietary, hydrogel based products for the spine and other surgical applications, announced today that it has received a CE mark for its GelFix Posterior Spinal Distraction implant. A CE mark is the quality assurance certification requirement recognized by members of the European Union for sales into those countries.

8 Mar 2010

biospace med receives FDA 510(k) clearance for sterEOS 2D/3D workstation for pediatric use in spine applications

biospace med announced today that it has received 510(k) clearance from the FDA to market the Company’s sterEOS 2D/3D workstation for pediatric use in spine applications. The Company’s EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine.

8 Mar 2010

Democrats pressure Stupak on abortion; Split threatening health bill

A split among Democrats on abortion is threatening to derail efforts to overhaul the nation's health care system.

8 Mar 2010

Medical News

FDA approves Taro Pharmaceutical Industries' Fluorouracil Topical Cream ANDA

BioSpecifics Technologies' XIAFLEX now available to Dupuytren's contracture patients in the U.S.

How health reform could affect 'young invincibles'

FDA grants Axis Surgical Technologies marketing clearance for C-MOR Visualization Device

Fact check: Do 15,000 people lose insurance every day?

State of Pennsylvania awards Medicaid managed care contract to Aetna Better Health

White House emphasizes rising health insurance costs as reason for reform

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Reconciliation update: Some Dems, GOP and industry groups wary health bill strategy

Response Genetics to raise $4M from private placement of over 3M newly issued shares

invendo medical seeks premarket clearance for new C20 colonoscopy system

Repeated anaesthesia in children linked to memory impairment

Prism Medical announces revenues of $65.7M for fiscal 2009

Positive interim results from NxStage Medical's FREEDOM study in RLS

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Rexahn Pharmaceuticals granted Japanese patent for Archexin

Gentiva Health Services acquires Heart to Heart Hospice

Replication Medical receives CE mark for GelFix Posterior Spinal Distraction implant

biospace med receives FDA 510(k) clearance for sterEOS 2D/3D workstation for pediatric use in spine applications

Democrats pressure Stupak on abortion; Split threatening health bill

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News